TCRX NASDAQ
TScan Therapeutics, Inc.
1W: -5.7%
1M: -15.9%
3M: -69.5%
YTD: -68.6%
1Y: -84.7%
3Y: -88.0%
5Y: -95.9%
$0.32
+0.00 (+0.94%)
Weekly Expected Move ±11.0%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$7M
Revenue
+2.2% YoY
$-118M
Net Income
+13.9% YoY
$-118M
Free Cash Flow
+9.8% YoY
100.0%
Gross Margin
-2901.3%
Op. Margin
-2888.6%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-95.8%
ROA-50.1%
ROIC-159.4%
Valuation
P/E-0.4
P/B0.6
EV/EBITDA-1.1
Leverage
Debt/Equity1.32
Current Ratio3.37
Interest Cov.-41.2x
Quality Scores
Piotroski F2/9
Altman Z-5.51
Beneish M-3.52